肥胖孕妇妊娠期糖尿病的代谢谱分析
本研究为UPBEAT随机对照试验的二次分析,纳入646名肥胖孕妇(198例发生妊娠期糖尿病),在平均孕17周0天和孕27周5天(口服葡萄糖耐量试验时)检测163种分析物。发生妊娠期糖尿病者在诊断前至少10周即出现脂质、脂蛋白、氨基酸、脂肪酸、酮体、脂肪因子及炎症标志物等代谢谱差异。
要点
- 肥胖孕妇中,日后发生妊娠期糖尿病者在孕17周左右即出现代谢谱差异。
- 差异涉及VLDL亚类脂质、脂蛋白颗粒甘油三酯富集、支链及芳香族氨基酸等。
- 代谢差异在孕27周5天口服葡萄糖耐量试验诊断前至少10周已可检出。
核心结论
- 在肥胖孕妇中,包括 exaggerated dyslipidaemia 在内的代谢谱差异在晚孕期第二孕期诊断妊娠期糖尿病前至少10周即已明显。
研究设计与样本
- 本研究为前瞻性队列研究,是英国妊娠更好饮食与活动试验(UPBEAT)的二次分析,该试验为针对肥胖孕妇复杂生活方式干预的多中心随机对照试验。
- 共研究646名妇女,其中198名发生妊娠期糖尿病。
- 在时间点1(平均孕17周0天)和时间点2(平均孕27周5天,口服葡萄糖耐量试验时)检测血清、血浆或全血中163种分析物,包括147种来自靶向核磁共振代谢组。
- 采用多变量回归分析,校正多重检验及包括研究干预在内的适当混杂因素,比较发生与未发生妊娠期糖尿病的肥胖孕妇。
主要发现
- 发生妊娠期糖尿病者与未发生者相比,多个代谢物差异显著(错误发现率校正P值<0.05),多数差异在诊断前即已明显。
- 发生妊娠期糖尿病者显示VLDL亚类中脂质和脂蛋白成分升高、脂蛋白颗粒中甘油三酯富集增加、支链和芳香族氨基酸升高。
- 发生妊娠期糖尿病者与未发生者相比,脂肪酸、酮体、脂肪因子、肝脏及炎症标志物谱不同。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Antenatal obesity and associated gestational diabetes (GDM) are increasing worldwide. While pre-existing insulin resistance is implicated in GDM in obese women, the responsible metabolic pathways remain poorly described. Our aim was to compare metabolic profiles in blood of obese pregnant women with and without GDM 10 weeks prior to and at the time of diagnosis by OGTT. METHODS: We investigated 646 women, of whom 198 developed GDM, in this prospective cohort study, a secondary analysis of UK Pregnancies Better Eating and Activity Trial (UPBEAT), a multicentre randomised controlled trial of a complex lifestyle intervention in obese pregnant women. Multivariate regression analyses adjusted for multiple testing, and accounting for appropriate confounders including study intervention, were performed to compare obese women with GDM with obese non-GDM women. We measured 163 analytes in serum, plasma or whole blood, including 147 from a targeted NMR metabolome, at time point 1 (mean gestational age 17 weeks 0 days) and time point 2 (mean gestational age 27 weeks 5 days, at time of OGTT) and compared them between groups. RESULTS: Multiple significant differences were observed in women who developed GDM compared with women without GDM (false discovery rate corrected p values <0.05). Most were evident prior to diagnosis. Women with GDM demonstrated raised lipids and lipoprotein constituents in VLDL subclasses, greater triacylglycerol enrichment across lipoprotein particles, higher branched-chain and aromatic amino acids and different fatty acid, ketone body, adipokine, liver and inflammatory marker profiles compared with those without GDM. CONCLUSIONS/INTERPRETATION: Among obese pregnant women, differences in metabolic profile, including exaggerated dyslipidaemia, are evident at least 10 weeks prior to a diagnosis of GDM in the late second trimester.
引用
- White SL, Pasupathy D, Sattar N, et al. Metabolic profiling of gestational diabetes in obese women during pregnancy. Diabetologia. 2017. PMID: 28766127. doi:10.1007/s00125-017-4380-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。